剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

已收盘 05-19 16:08:19

20.060

-3.300

-14.13%

最高23.320	最低19.120	成交量866.82万
今开23.320	昨收23.360	日振幅17.98%
总市值231.19亿	流通市值211.22亿	总股本11.53亿
成交额1.77亿	换手率0.82%	流通股本10.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":20.06,"timestamp":1779178099150,"preClose":23.36,"halted":0,"volume":8668220,"delay":0,"changeRate":-0.14126712328767127,"floatShares":1052926111,"shares":1152513850,"eps":0,"marketStatus":"已收盘","change":-3.3,"latestTime":"05-19 16:08:19","open":23.32,"high":23.32,"low":19.12,"amount":177456580,"amplitude":0.179795,"askPrice":20.08,"askSize":11000,"bidPrice":20.06,"bidSize":23000,"shortable":0,"etf":0,"ttmEps":-0.376,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":23.36,"openAndCloseTimeList":[[1779154200000,1779163200000],[1779166800000,1779177600000]],"volumeRatio":0.282383,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"1188442804","title":"异动解读 | 剂泰科技-P盘中大跌5.48%，IPO后持续回调新股热度消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1188442804","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188442804?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:54","pubTimestamp":1779155647,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大跌5.48%，引发了市场的关注。消息面上，剂泰科技作为全球AI药物递送第一股，近期刚刚完成首次公开募股并上市。然而，公司在上市首日经历大幅上涨后，股价正进入持续回调阶段。这主要由于公司尚处于商业化的早期阶段，过去三年累计亏损约15亿元人民币，营收表现波动，其未来的业绩增长潜力仍需时间来验证。此外，部分国际配售的股份在上市后并未设置禁售期，这导致了潜在的获利了结压力。随着新股上市初期的市场热度逐渐消退，股价面临的下行压力也随之显现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636049383","title":"港股剂泰科技-P午前涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636049383","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636049383?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:56","pubTimestamp":1779076619,"startTime":"0","endTime":"0","summary":"5月18日，剂泰科技-P(07666.HK)午前涨超4%，截至发稿，涨3.5%，报22.46港元，成交额6295.67万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740200963.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740200963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","VXUS","07666","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636459100","title":"剂泰科技(07666)OpenCGT平台累计合作额超60亿 最新联手沙砾生物达成免疫靶向递送技术合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2636459100","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636459100?lang=zh_cn&edition=full","pubTime":"2026-05-18 10:59","pubTimestamp":1779073183,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技今日宣布，与肿瘤免疫细胞治疗企业沙砾生物正式签署全面技术合作战略协议，双方将围绕免疫靶向脂质纳米颗粒递送技术展开合作，共同推进新一代体内免疫治疗产品的研发与转化。此次合作依托剂泰科技自研的全球首个AI纳米递送平台NanoForge，是该平台赋能OpenCGT项目的又一重要里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125108383","title":"异动解读 | 剂泰科技-P盘中大跌7.1%，新股热度消退叠加基本面担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1125108383","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125108383?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:40","pubTimestamp":1779068418,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大幅下挫，跌幅达到7.10%，市场表现引人关注。消息面上，剂泰科技作为全球AI药物递送第一股，于近期登陆港交所，上市首日曾录得显著涨幅。然而，新股热度正逐渐消退，股价自高点持续回调。公司目前仍处于商业化早期阶段，过去三年累计亏损约15亿元，营收表现波动，未来业绩增长前景尚需时间验证。此外，有市场分析指出，该股部分国际配售股份未设置禁售期，上市后存在一定的获利了结压力，这也是导致股价承压回落的重要因素之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147331990","title":"异动解读 | 剂泰科技上市次日盘中大涨5.04%，AI药物递送第一股受热捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1147331990","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147331990?lang=zh_cn&edition=full","pubTime":"2026-05-14 09:39","pubTimestamp":1778722773,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.04%，延续了其上市首日的强劲表现。消息面上，剂泰科技于昨日正式在港交所挂牌上市，成为“全球AI药物递送第一股”及“港股AI大分子生物制药第一股”。剂泰科技的核心竞争力源于其自主研发的全球首个AI驱动纳米递送平台NanoForge，并基于此开发了多条产品管线。其中，核心产品MTS-004是中国首款完成III期临床的AI赋能制剂新药。这些积极的上市因素和公司基本面增强了市场信心，推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227610","title":"剂泰科技-P首挂上市 早盘上涨175.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227610","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635227610?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:36","pubTimestamp":1778636160,"startTime":"0","endTime":"0","summary":"　　剂泰科技-P首挂上市，公告显示，每股定价10.5港元，共发行2.01亿股股份，每手500股，所得款项净额约为19.93亿港元。截至发稿，股价上涨175.05%，现报28.88港元，成交额13.90亿港元。　　招股书显示，剂泰科技是一家AI纳米材料创新企业，致力于有效载荷在不同生命体中的递送与应用。　　管线方面，剂泰科技已布局超过10款产品，覆盖中枢神经、肿瘤、免疫、代谢等方向。其中，MTS-004为公司进展较快的候选产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2026-05-13/doc-inhxteir7736326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106879812","title":"剂泰科技-P香港首秀：开盘价定为每股28.68港元，较发行价飙升173%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106879812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106879812?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:21","pubTimestamp":1778635294,"startTime":"0","endTime":"0","summary":"备受瞩目的生物科技股剂泰科技-P（METIS TECHBIO-P）今日在香港交易所闪亮登场。其开盘价定于每股28.68港元，与10.50港元的发行价相比，实现了高达173%的惊人涨幅，为市场注入了一剂强心针。\n这一显著溢价充分反映了投资者对该公司所处赛道及其技术前景的浓厚兴趣与强烈信心。首日交易的表现，无疑将成为观察近期新股市场情绪与资金流向的关键风向标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100453375","title":"港股开盘 | 恒指高开0.08%，科指低开0.3%！剂泰科技-P首挂涨超173%、英派药业-B首挂涨超76%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100453375","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100453375?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:20","pubTimestamp":1778635230,"startTime":"0","endTime":"0","summary":"5月13日，港股开盘，恒指开涨0.08%，科指开跌0.3%。京东涨超3%，Q1营收同比小幅增长，调整后EBITDA远超预期，外卖业务亏损环比大幅收窄；泡泡玛特涨近4%，Q1收入预增75％至80％，欧美市场增长放缓，中国线上渠道预增150%；剂泰科技-P首挂涨超173%，公开发售阶段获6910.96倍认购，一手中签率0.14%；英派药业-B首挂涨超76%，公开发售阶段获2282.4倍认购，一手中签率1.5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"18a40ba5e41ea1a9f349b7fe41577e93","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03032","VXUS","03115","BK4588","02800","09115","07300","03423","07226","09088","03037","02837","03419","07666","82800","513600","07200","07552","07500","07630","03067","BK4585","09067","HSI","03417","83115","02833","03088","03033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130859403","title":"新股定价 | 剂泰科技发售价为每股10.50港元，超购6900倍、一手中签率0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130859403","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130859403?lang=zh_cn&edition=full","pubTime":"2026-05-13 08:14","pubTimestamp":1778631245,"startTime":"0","endTime":"0","summary":" $剂泰科技-P(07666)$ (07666)今日挂牌，公司在香港公开发售录得超6900倍超额认购，锁定认购资金逾7300亿港元，为2026年迄今港股医疗健康IPO香港公开发售认购金额之最，也是年内港股IPO新的“冻资王”；国际配售方面，获得超过208个机构投资人下单，录得可分配额度33.86倍的认购，也是2026年迄今港股医疗健康IPO国际配售认购倍数之最。根据招股安排，发售价为每股10.50港元，每手500股，一手中签率0.14%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/65177b251c5404b4130d2fb6d0eaa1e8","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/65177b251c5404b4130d2fb6d0eaa1e8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"新股定价 | 剂泰科技发售价为每股10.50港元，超购6900倍、一手中签率0.14%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635466022","title":"【新股IPO】剂泰科技(07666)一手中签率0.14% 超额认购6910.96倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2635466022","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635466022?lang=zh_cn&edition=full","pubTime":"2026-05-13 00:21","pubTimestamp":1778602910,"startTime":"0","endTime":"0","summary":"本次全球发售 201,229,000股H股，香港公开发售占比20%，国际发售占比80%；超额配售权涉及30,184,000股，稳定价格操作人为中信里昂证券，稳定价格期至2026年6月7日止。香港公开发售获大幅超额认购，有效申请383,309份，认购倍数约6910.96倍，一手中签率0.14%。公司已引入18名基石投资者，合共认购110,415,000股发售股份，占全球发售股份总数约54.87%，相关股份设6个月禁售期。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/ODZjNDc2NzhkMGI4M2ExNWZiZmY1ZTEwODUxMzY0OTQ0NQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ODZjNDc2NzhkMGI4M2ExNWZiZmY1ZTEwODUxMzY0OTQ0NQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981203","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","SPCX","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634329186","title":"新股暗盘 | “AI药物递送第一股”剂泰科技-P(07666)暗盘强势走高 最高涨近320%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634329186","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634329186?lang=zh_cn&edition=full","pubTime":"2026-05-12 16:57","pubTimestamp":1778576239,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月12日，“AI药物递送第一股”剂泰科技-P暗盘交易获市场持续追捧，截至发稿，显示最高报价44港元，较招股价10.5港元上涨319%，每手500股，不计手续费，每手可赚16750港元。作为AI纳米材料创新的领军者，剂泰科技致力于有效载荷在各种生命体中的递送与应用。目前，剂泰科技已构建了全球规模最大、最多元化的脂质库，收录了超过1000万种结构多元化的脂质。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e108fe6f590fa4e8d42fd22434eaf220","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666","AGIX","CHAT","AIPO","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106713977","title":"老虎暗盘｜剂泰科技-P暴涨280%，总市值超460亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106713977","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106713977?lang=zh_cn&edition=full","pubTime":"2026-05-12 16:16","pubTimestamp":1778573775,"startTime":"0","endTime":"0","summary":"5月12日，$剂泰科技-P$暗盘暴涨280%，总市值超460亿港元，每股定价10.50港元，每手500股；将于5月13日（周三）正式在港交所挂牌交易。剂泰科技是一家AI驱动的生物科技公司，专注于药物纳米递送的材料开发与技术创新。NanForge可使4小分子药物的剂型研发从1-2年缩短到3个月，并可实现靶向肝脏、肌肉、肿瘤及免疫系统等8个器官或组织的精准药物递送。同时，公司与全球超过30家医药及生物技术公司建立了新药研发合作关系。","market":"hk","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633918418","title":"新股孖展统计 | 5月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633918418","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633918418?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:27","pubTimestamp":1778063248,"startTime":"0","endTime":"0","summary":"英派药业-B(07630)、剂泰科技-P(07666)正在招股中。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260506/20260506182748_22433.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260506/20260506182748_22433.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["07630","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633699596","title":"1.48亿美元“买方天团”，剂泰科技（7666.HK）凭什么拿到这份顶配基石名单？","url":"https://stock-news.laohu8.com/highlight/detail?id=2633699596","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633699596?lang=zh_cn&edition=full","pubTime":"2026-05-05 11:24","pubTimestamp":1777951461,"startTime":"0","endTime":"0","summary":"“AI制药三小龙”齐聚港交所，谁的呼声最高，以及如何看？","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/137.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/137.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4622941","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["01477","AI","BK4588","BK4528","AGIX","AIPO","ARTY","BK1191","BK1574","BK4543","BK4585","CHAT","BK4023","07666","BK4551","VGT","AIYY","BK4587"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2633962253","title":"剂泰科技-P 5月5日至5月8日招股，拟全球发售2.01亿股H股，引入贝莱德等基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2633962253","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633962253?lang=zh_cn&edition=full","pubTime":"2026-05-05 07:01","pubTimestamp":1777935708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，剂泰科技-P 于2026年5月5日至2026年5月8日招股，该公司拟全球发售2.01亿股H股，其中，香港公开发售占约5%，国际发售占约95%，另有15%超额配股权。发售价每股10.5港元。集团于2023年、2024年及2025年分别取得毛利人民币560万元、人民币80万元及人民币1.03亿元，同期毛利率分别为59.8%、55.5%及 98.2%。集团于2025年的整体毛利率有所提升，主要来自期内确认MTS-004收入人民币1亿元。","market":"sh","thumbnail":"https://static.tigerbbs.com/0fac2e2b54b3ae646af9dc9fa51f62b1","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fac2e2b54b3ae646af9dc9fa51f62b1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437972.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1509826696.USD","LU1366333091.USD","LU1988902786.USD","IE00BVYPNV92.GBP","LU0320765489.SGD","IE00BGHQF631.EUR","BK4585","LU0772969993.USD","LU1670628061.USD","BK4567","LU1481011671.HKD","BK4504","LU0208291251.USD","IE00BDGV0183.EUR","IE00B64PRP62.GBP","IE00B3PB1722.GBP","LU2430703178.SGD","LU1074936037.SGD","IE00BGHQF748.EUR","LU0640476718.USD","LU2505996681.GBP","IE00B42XCP33.USD","LU2592432038.USD","BK4588","LU0731783048.USD","IE00BVYPNW00.USD","IE00B3QW5Z07.USD","LU2505996509.AUD","LU1481011911.USD","LU1280957306.USD","LU1291159041.SGD","LU2264538146.SGD","LU0130102774.USD","LU0731783394.SGD","LU2430703251.USD","LU0157215616.USD","BK4534","LU1201861249.SGD","LU0742537680.HKD","07666","LU1599440770.SGD","BK4533","BK4135","BK4535","LU1670627923.USD","BK4581","LU2430703095.HKD","LU0070302665.USD","LU1989771016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144798396","title":"荟泰科技（北京）启动全球发售：发行规模201,229,000股，每股发售价10.50港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144798396","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144798396?lang=zh_cn&edition=full","pubTime":"2026-05-05 06:22","pubTimestamp":1777933373,"startTime":"0","endTime":"0","summary":"─ 2026年5月5日，荟泰科技（北京）股份有限公司宣布正式启动全球发售，拟发行201,229,000股H股，发行价格每股10.50港元，包含香港公开发售及国际配售两部分。其中，香港公开发售10,061,500股，国际发售191,167,500股，并设有最高不超过本次发售规模15%的超额配股权（如有）。公司预计H股将于2026年5月13日（星期三）上午九时正开始在香港联交所买卖，股票代码：07666。公司披露，本次全球发售已获若干基石投资者认购合共10,415,000股发售股份，认购价同为每股10.50港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荟泰科技（北京）启动全球发售：发行规模201,229,000股，每股发售价10.50港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":1.2248},{"period":"ytd","weight":1.2248}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0185},{"period":"3month","weight":-0.0386},{"period":"6month","weight":-0.006},{"period":"1year","weight":0.0998},{"period":"ytd","weight":0.0017}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"AI纳米递送,开启健康未来。剂泰科技是一家人工智能(AI)驱动纳米材料创新的生物科技公司,专注于利用靶向药物递送和发现技术,加速患者在重要疾病领域获得创新疗法。\n公司由美国工程院院士陈红敏博士以及MIT科学家赖才达博士、王文首博士联合创立,成功自主开发了AI纳米基座大模型及三大核心解决方案:AiLNP(AI纳米递送系统设计平台)、AiRNA(AI mRNA序列设计平台)、AiTEM(AI小分子制剂设计平台)。\n公司已具备实现肝脏、肺部、肌肉和免疫细胞等关键组织和细胞的LNP精准靶向递送能力,在多器官、多组织靶向递送难题上取得突破性进展,为肿瘤、代谢系统疾病、自体免疫性疾病、神经系统退行性疾病等提供成药机会。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}